Mutares Faces Investor Scrutiny Amid Strong Operational Performance

Mutares posts record €6.5B revenue but breaches leverage covenant, triggering a share drop and urgent plan for asset sales and acquisitions to fix its balance sheet.

Investment holding company Mutares finds itself in a paradoxical position. While announcing record-breaking operational results for the full year 2025, management has simultaneously requested a formal waiver from its bondholders. The request stems from a technical breach of balance sheet covenants, creating a stark contrast between robust underlying growth and immediate financial formalities that is currently weighing on investor sentiment.

Operational Strength Overshadowed by Covenant Concern

At the heart of the matter is the company's leverage ratio—the relationship between net debt and equity—which exceeded agreed limits as of the December 31, 2025 reporting date. Mutares has asked investors in two of its corporate bonds to suspend testing this covenant until June 30, 2026. According to the company, the breach is primarily attributable to accounting effects from IFRS 16 lease liabilities, coupled with fewer successful portfolio company exits than anticipated in the final quarter of the year.

Operationally, the Munich-based firm delivered a powerful performance. Consolidated revenue for 2025 climbed to approximately €6.5 billion. The holding company's net income also saw significant improvement, reaching €130.4 million. A strong group EBITDA of €733.5 million was largely driven by advantageous acquisitions. However, the adjusted operating result remained in negative territory at -€27.8 million.

Market Reaction and the Path Forward

The disclosure of the covenant breach prompted noticeable investor caution in the stock market. The shares have declined 13.80 percent over the past month, closing Friday's session at €28.10. To swiftly reinforce its financial foundation and rectify its balance sheet ratios, management is now accelerating a substantial wave of transactions.

A decisive series of deals is planned for the second quarter of 2026. The company aims to finalize four divestments, including stakes in Relobus and Kalzip. Concurrently, Mutares is preparing additional lucrative exits within the currently high-valued energy and defense sectors. On the acquisition side, five takeovers are nearing completion, such as the purchase of Wärtsilä's Gas Solutions division.

The bondholder vote on waiving the covenant test is widely considered a procedural formality in the market. Should the company successfully execute its ambitious transaction pipeline this spring, the balance sheet pressure is expected to dissipate rapidly. Analysts at Warburg Research maintain that the operational potential remains intact, reiterating a price target of €46 per share. Their assessment is supported by an earnings forecast for the current fiscal year that already sits notably above prevailing market expectations.